— Drugs Extending My Life, but Boston Institute Disagrees. Click here to read the op-ed.
— How CMS Can Advance – or Impede – Patient-Centered Decision-Making in its New Drug Pricing Program. Click here to read the column,
— QALYs: The Math Doesn’t Work. Click here to read the article.
— Opinion: Drug Pricing and the 'Impossible Trinity' for Patients. Click here to read the op-ed.
— PIPC Collaborates with Avalere on Investigation of Use of Patient-Centered Outcomes in Value Assessment. See details below.
— CCD Pens Letter of Support for Protecting Healthcare for All Patients Act. Click here to read the letter.
— Chairman's Corner: I introduced the ADA 35 years ago. Now Congress needs to act to ban a practice that devalues disabled lives. Click here to read the op-ed.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.
— AHRQ Effective Program Updates. See details below.